ABT-510
id:
abt-510-240-3207195
title:
ABT-510
text:
ABT-510 is a molecular therapeutic drug that was the subject of research as a potential treatment for cancer. According to the Journal of Clinical Oncology, ABT-510 is a "subcutaneously (SC) administered nonapeptide thrombospondin analogue." Following inconclusive phase I clinical trials, a 2007 phase II study of ABT-510 for treatment of metastatic melanoma failed to reach its primary endpoint resulting in termination of the study. Only three out of twenty-one patients reached the primary endpoi
brand slug:
wiki
category slug:
encyclopedia
description:
Molecular therapeutic drug that was studied as a treatment for cancer
original url:
https://en.wikipedia.org/wiki/ABT-510
date created:
date modified:
2023-08-28T14:53:50Z
main entity:
{"identifier":"Q27095674","url":"https://www.wikidata.org/entity/Q27095674"}
image:
fields total:
13
integrity:
14